Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03521206Not ApplicableCompleted

Advance Care Planning in Nursing Homes in Flanders

Role: lead

NCT01890239Not ApplicableCompleted

The Effectiveness of the Care Programme for the Last Days of Life

Role: lead

NCT02060877Completed

Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung Disease

Role: collaborator

All 3 trials loaded